keyword
https://read.qxmd.com/read/38647700/de-novo-drug-design-as-gpt-language-modeling-large-chemistry-models-with-supervised-and-reinforcement-learning
#21
JOURNAL ARTICLE
Gavin Ye
In recent years, generative machine learning algorithms have been successful in designing innovative drug-like molecules. SMILES is a sequence-like language used in most effective drug design models. Due to data's sequential structure, models such as recurrent neural networks and transformers can design pharmacological compounds with optimized efficacy. Large language models have advanced recently, but their implications on drug design have not yet been explored. Although one study successfully pre-trained a large chemistry model (LCM), its application to specific tasks in drug discovery is unknown...
April 22, 2024: Journal of Computer-aided Molecular Design
https://read.qxmd.com/read/38647679/ultrasonic-synthesis-of-green-lipid-nanocarriers-loaded-with-scutellaria-barbata-extract-a-sustainable-approach-for-enhanced-anticancer-and-antibacterial-therapy
#22
JOURNAL ARTICLE
Raghu Jetti, Maritza Lucia Vaca Cárdenas, Haider Falih Shamikh Al-Saedi, Shaymaa Abed Hussein, Hussam Abdali Abdulridui, Salah Hassan Zain Al-Abdeen, Usama Kadem Radi, Adnan Hashim Abdulkadhim, Sahar Balkit Hussein, Ahmed Alawadi, Ali Alsalamy
Ultrasonic manufacturing has emerged as a promising eco-friendly approach to synthesize lipid-based nanocarriers for targeted drug delivery. This study presents the novel ultrasonic preparation of lipid nanocarriers loaded with Scutellaria barbata extract, repurposed for anticancer and antibacterial use. High-frequency ultrasonic waves enabled the precise self-assembly of DSPE-PEG, Span 40, and cholesterol to form nanocarriers encapsulating the therapeutic extract without the use of toxic solvents, exemplifying green nanotechnology...
April 22, 2024: Bioprocess and Biosystems Engineering
https://read.qxmd.com/read/38647675/stilbenes-a-journey-from-folklore-to-pharmaceutical-innovation
#23
REVIEW
Gursharan Kaur, Rajinder Kaur, Gurleen Kaur Sodhi, Nancy George, Santosh Kumar Rath, Harleen Kaur Walia, Vagish Dwibedi, Sanjai Saxena
In modern times, medicine is predominantly based on evidence-based practices, whereas in ancient times, indigenous people relied on plant-based medicines with factual evidence documented in ancient books or folklore that demonstrated their effectiveness against specific infections. Plants and microbes account for 70% of drugs approved by the USFDA (U.S. Food and Drug Administration). Stilbenes, polyphenolic compounds synthesized by plants under stress conditions, have garnered significant attention for their therapeutic potential, bridging ancient wisdom with modern healthcare...
April 22, 2024: Archives of Microbiology
https://read.qxmd.com/read/38647541/biological-synthesis-of-silver-nanoparticles-from-lavandula-mairei-humbert-antibacterial-and-antioxidant-activities
#24
JOURNAL ARTICLE
Soufiane El Megdar, Lahbib Fayzi, Raja Elkheloui, Asma Laktib, Mohamed Bourouache, Abdellah El Boulani, Hicham Abou Oualid, Khalil Cherifi, Fouad Msanda, Mohamed Hassi, Rachida Mimouni, Fatima Hamadi
Hospital-acquired infections involving carbapenem-resistant Acinetobacter baumannii (A. baumannii) and extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae pose significant challenges in the intensive care units. The lack of novel antimicrobial drugs amplifies the urgency to explore innovative management strategies. Nanotechnology, with its ability to generate nanoparticles possessing specific properties beneficial in drug delivery and nanomedicine, stands as a pivotal research domain. The objective of this study was to synthesize, for the first time, biologically silver nanoparticles (Ag-NPs) from Lavandula mairei Humbert (L...
April 22, 2024: Current Microbiology
https://read.qxmd.com/read/38647152/eravacycline-an-antibacterial-drug-repurposed-for-pancreatic-cancer-therapy-insights-from-a-molecular-based-deep-learning-model
#25
JOURNAL ARTICLE
Adi Jabarin, Guy Shtar, Valeria Feinshtein, Eyal Mazuz, Bracha Shapira, Shimon Ben-Shabat, Lior Rokach
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains a serious threat to health, with limited effective therapeutic options, especially due to advanced stage at diagnosis and its inherent resistance to chemotherapy, making it one of the leading causes of cancer-related deaths worldwide. The lack of clear treatment directions underscores the urgent need for innovative approaches to address and manage this deadly condition. In this research, we repurpose drugs with potential anti-cancer activity using machine learning (ML)...
March 27, 2024: Briefings in Bioinformatics
https://read.qxmd.com/read/38646959/current-state-and-advances-in-desensitization-for-peanut-allergy-in-pediatric-age
#26
REVIEW
Simone Foti Randazzese, Ilenia Panasiti, Lucia Caminiti, Francesco Catamerò, Massimo Landi, Maria De Filippo, Martina Votto, Roberta Olcese, Filippo Favuzza, Mattia Giovannini, Salvatore Barberi
Peanut allergy affects about 1%-3% of the pediatric population in the world, with an important increase in the last decades. Nowadays, international guidelines recommend the early introduction of peanuts in the infant diet, with poor information about the quantity and the frequency of the intake. Allergen immunotherapy may represent the only therapeutic strategy able to modify the natural history of peanut allergy. In particular, oral immunotherapy showed the most promising results in terms of efficacy, but with significant rates of adverse reactions, mostly gastrointestinal...
April 2024: Pediatric Allergy and Immunology
https://read.qxmd.com/read/38646682/a-review-on-tau-targeting-biomimetics-nano-formulations-novel-approach-for-targeting-alzheimer-s-diseases
#27
JOURNAL ARTICLE
Aditya Singh, Shubhrat Maheshwari, Jagat Pal Yadav, Aditya Prakash Varshney, Sudarshan Singh, Bhupendra G Prajapati
Central nervous system disorders are prevalent, profoundly debilitating, and poorly managed. Developing innovative treatments for these conditions, including Alzheimer's disease, could significantly improve patients' quality of life and reduce the future economic burden on healthcare systems. However, groundbreaking drugs for central nervous system disorders have been scarce in recent years, highlighting the pressing need for advancements in this field. One significant challenge in the realm of nanotherapeutics is ensuring the precise delivery of drugs to their intended targets due to the complex nature of Alzheimer's disease...
March 25, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38646652/theranostics-and-artificial-intelligence-new-frontiers-in-personalized-medicine
#28
REVIEW
Gokce Belge Bilgin, Cem Bilgin, Brian J Burkett, Jacob J Orme, Daniel S Childs, Matthew P Thorpe, Thorvardur R Halfdanarson, Geoffrey B Johnson, Ayse Tuba Kendi, Oliver Sartor
The field of theranostics is rapidly advancing, driven by the goals of enhancing patient care. Recent breakthroughs in artificial intelligence (AI) and its innovative theranostic applications have marked a critical step forward in nuclear medicine, leading to a significant paradigm shift in precision oncology. For instance, AI-assisted tumor characterization, including automated image interpretation, tumor segmentation, feature identification, and prediction of high-risk lesions, improves diagnostic processes, offering a precise and detailed evaluation...
2024: Theranostics
https://read.qxmd.com/read/38645731/utilizing-surface-plasmon-resonance-as-a-novel-method-for-monitoring-in-vitro-p-glycoprotein-efflux
#29
JOURNAL ARTICLE
Phuong H Nguyen, Shuolin Cui, Amanda M Kozarich, Alex Rautio, Arthur G Roberts, May P Xiong
P-glycoprotein (Pgp) is known for its dichotomous roles as both a safeguarding efflux transporter against xenobiotics and as a catalyst for multidrug resistance. Given the susceptibility of numerous therapeutic compounds to Pgp-mediated resistance, compliance with Food and Drug Administration (FDA) guidelines mandates an in-depth in vitro transport assay during drug development. This study introduces an innovative transport assay that aligns with these regulatory imperatives but also addresses limitations in the currently established techniques...
2024: Front Biophys
https://read.qxmd.com/read/38645527/current-status-of-controlled-onco-therapies-based-on-metal-organic-frameworks
#30
REVIEW
Yixuan Yang, Xiaofeng Dai
Despite consecutive efforts devoted to the establishment of innovative therapeutics for cancer control, cancer remains as a primary global public health concern. Achieving controlled release of anti-cancer agents may add great value to the field of oncology that requires the involvement of nanotechnologies. Metal organic frameworks (MOFs) hold great promise in this regard owing to their unique structural properties. MOFs can act as superior candidates for drug delivery given their porous structure and large loading area, and can be prepared into anti-cancer therapeutics by incorporating stimuli-sensitive components into the ligands or nodes of the framework...
April 16, 2024: RSC Advances
https://read.qxmd.com/read/38645276/restoring-cellular-copper-homeostasis-in-alzheimer-disease-a-novel-peptide-shuttle-is-internalized-by-an-atp-dependent-endocytosis-pathway-involving-rab5-and-rab14-endosomes
#31
JOURNAL ARTICLE
Michael Okafor, Olivia Champomier, Laurent Raibaut, Sebahat Ozkan, Naima El Kholti, Stéphane Ory, Sylvette Chasserot-Golaz, Stéphane Gasman, Christelle Hureau, Peter Faller, Nicolas Vitale
CPPs, or Cell-Penetrating Peptides, offer invaluable utility in disease treatment due to their ability to transport various therapeutic molecules across cellular membranes. Their unique characteristics, such as biocompatibility and low immunogenicity, make them ideal candidates for delivering drugs, genes, or imaging agents directly into cells. This targeted delivery enhances treatment efficacy while minimizing systemic side effects. CPPs exhibit versatility, crossing biological barriers and reaching intracellular targets that conventional drugs struggle to access...
2024: Frontiers in Molecular Biosciences
https://read.qxmd.com/read/38645066/nor-laam-loaded-plga-microparticles-for-treating-opioid-use-disorder
#32
Diane Ingabire, Chaolong Qin, Tuo Meng, Aji Alex Moothendathu Raynold, Hadi Sudarjat, E Andrew Townsend, Rudra Pangeni, Sagun Poudel, Michelle Arriaga, Long Zhao, Woon N Chow, Matthew Banks, Qingguo Xu
The treatment landscape for opioid use disorder (OUD) faces challenges stemming from the limited efficacy of existing medications, poor adherence to prescribed regimens, and a heightened risk of fatal overdose post-treatment cessation. Therefore, there is a pressing need for innovative therapeutic strategies that enhance the effectiveness of interventions and the overall well-being of individuals with OUD. This study explored the therapeutic potential of nor-Levo-α-acetylmethadol (nor-LAAM) to treat OUD...
April 11, 2024: bioRxiv
https://read.qxmd.com/read/38644722/nanotechnology-in-orthodontics-unveiling-pain-mechanisms-innovations-and-future-prospects-of-nanomaterials-in-drug-delivery
#33
JOURNAL ARTICLE
Divya Sharma, Shiv Kumar, Yogesh Garg, Shruti Chopra, Amit Bhatia
Orthodontic pain is characterized by sensations of tingling, tooth discomfort, and intolerance. According to the oral health report, over forty percent of children and adolescents have undergone orthodontic treatment. The efficacy of orthodontic treatment involving braces can be compromised by the diverse levels of discomfort and suffering experienced by patients, leading to suboptimal treatment outcomes and reduced patient adherence. Nanotechnology has entered all areas of science and technology. This review provides an overview of nanoscience, its application in orthodontics, the underlying processes of orthodontic pain, effective treatment options, and a summary of recent research in Nano-dentistry...
April 19, 2024: Current Pharmaceutical Design
https://read.qxmd.com/read/38644715/1-3-4-oxadiazole-scaffold-in-antidiabetic-drug-discovery-an-overview
#34
JOURNAL ARTICLE
Ojasvi Gupta, Gita Chawla, Tathagata Pradhan
Diabetes mellitus is one of the biggest challenges for the scientific community in the 21st century. With the increasing number of cases of diabetes and drug-resistant diabetes, there is an urgent need to develop new potent molecules capable of combating this cruel disease. Medicinal chemistry concerns the discovery, development, identification, and interpretation of the mode of action of biologically active compounds at the molecular level. Oxadiazole-based derivatives have come up as a potential option for antidiabetic drug research...
April 19, 2024: Mini Reviews in Medicinal Chemistry
https://read.qxmd.com/read/38644459/detection-algorithms-for-gastrointestinal-perforation-cases-in-the-medical-information-database-network-mid-net-%C3%A2-in-japan
#35
JOURNAL ARTICLE
Masatoshi Tanigawa, Mei Kohama, Kaori Hirata, Rieko Izukura, Tadashi Kandabashi, Yoko Kataoka, Naoki Nakashima, Michio Kimura, Yoshiaki Uyama, Hideto Yokoi
BACKGROUND: The Medical Information Database Network (MID-NET® ) in Japan is a vast repository providing an essential pharmacovigilance tool. Gastrointestinal perforation (GIP) is a critical adverse drug event, yet no well-established GIP identification algorithm exists in MID-NET® . METHODS: This study evaluated 12 identification algorithms by combining ICD-10 codes with GIP therapeutic procedures. Two sites contributed 200 inpatients with GIP-suggestive ICD-10 codes (100 inpatients each), while a third site contributed 165 inpatients with GIP-suggestive ICD-10 codes and antimicrobial prescriptions...
April 21, 2024: Therapeutic Innovation & Regulatory Science
https://read.qxmd.com/read/38644388/genetic-insights-into-agronomic-and-morphological-traits-of-drug-type-cannabis-revealed-by-genome-wide-association-studies
#36
JOURNAL ARTICLE
Maxime de Ronne, Éliana Lapierre, Davoud Torkamaneh
Cannabis sativa L., previously concealed by prohibition, is now a versatile and promising plant, thanks to recent legalization, opening doors for medical research and industry growth. However, years of prohibition have left the Cannabis research community lagging behind in understanding Cannabis genetics and trait inheritance compared to other major crops. To address this gap, we conducted a comprehensive genome-wide association study (GWAS) of nine key agronomic and morphological traits, using a panel of 176 drug-type Cannabis accessions from the Canadian legal market...
April 22, 2024: Scientific Reports
https://read.qxmd.com/read/38643841/cell-membrane-coated-nanoparticles-for-targeting-carcinogenic-bacteria
#37
REVIEW
Lei Sun, Dan Wang, Kailin Feng, Jiayuan Alex Zhang, Weiwei Gao, Liangfang Zhang
The etiology of cancers is multifactorial, with certain bacteria established as contributors to carcinogenesis. As the understanding of carcinogenic bacteria deepens, interest in cancer treatment through bacterial eradication is growing. Among emerging antibacterial platforms, cell membrane-coated nanoparticles (CNPs), constructed by enveloping synthetic substrates with natural cell membranes, exhibit significant promise in overcoming challenges encountered by traditional antibiotics. This article reviews recent advancements in developing CNPs for targeting carcinogenic bacteria...
April 19, 2024: Advanced Drug Delivery Reviews
https://read.qxmd.com/read/38643565/research-progress-of-protacs-for-neurodegenerative-diseases-therapy
#38
REVIEW
Zhifang Cai, Zunhua Yang, Huilan Li, Yuanying Fang
Neurodegenerative diseases (NDD) are characterized by the gradual deterioration of neuronal function and integrity, resulting in an overall decline in brain function. The existing therapeutic options for NDD, including Alzheimer's disease, Parkinson's disease, and Huntington's disease, fall short of meeting the clinical demand. A prominent pathological hallmark observed in numerous neurodegenerative disorders is the aggregation and misfolding of proteins both within and outside neurons. These abnormal proteins play a pivotal role in the pathogenesis of neurodegenerative diseases...
April 18, 2024: Bioorganic Chemistry
https://read.qxmd.com/read/38643301/impact-of-early-access-reform-on-oncology-innovation-in-france-approvals-patients-and-costs
#39
JOURNAL ARTICLE
Tess Martin, Catherine Rioufol, Bertrand Favier, Nicolas Martelli, Isabelle Madelaine, Christos Chouaid, Isabelle Borget
BACKGROUND: An ambitious reform of the early access (EA) process was set up in July 2021 in France, aiming to simplify procedures and accelerate access to innovative drugs. OBJECTIVE: This study analyzes the characteristics of oncology drug approvals through the EA process and its impact on real-life data for oncology patients. METHODS: The number and characteristics of EA demands concerning oncology drugs submitted to the National Health Authority (HAS, Haute Autorité de Santé) were reviewed until 31 December 2022...
April 20, 2024: BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
https://read.qxmd.com/read/38643164/a-patient-specific-lung-cancer-assembloid-model-with-heterogeneous-tumor-microenvironments
#40
JOURNAL ARTICLE
Yanmei Zhang, Qifan Hu, Yuquan Pei, Hao Luo, Zixuan Wang, Xinxin Xu, Qing Zhang, Jianli Dai, Qianqian Wang, Zilian Fan, Yongcong Fang, Min Ye, Binhan Li, Mailin Chen, Qi Xue, Qingfeng Zheng, Shulin Zhang, Miao Huang, Ting Zhang, Jin Gu, Zhuo Xiong
Cancer models play critical roles in basic cancer research and precision medicine. However, current in vitro cancer models are limited by their inability to mimic the three-dimensional architecture and heterogeneous tumor microenvironments (TME) of in vivo tumors. Here, we develop an innovative patient-specific lung cancer assembloid (LCA) model by using droplet microfluidic technology based on a microinjection strategy. This method enables precise manipulation of clinical microsamples and rapid generation of LCAs with good intra-batch consistency in size and cell composition by evenly encapsulating patient tumor-derived TME cells and lung cancer organoids inside microgels...
April 20, 2024: Nature Communications
keyword
keyword
160257
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.